We use cookies for a better user experience. Read our Privacy Policy

I Agree

Dry Eye Disease Treatment Market

Dry Eye Disease Treatment Market (Product: Artificial Tears, Anti-inflammatory [Cyclosporine, Corticosteroid, and Others], Punctal Plugs, Secretagogue, and Others; Disease: Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Telehealth Services Boost Uptake of Anti-inflammatory Products amidst COVID-19 Outbreak

Telemedicine consultations are being highly publicized for the management of dry eye disease amidst the coronavirus (COVID-19) pandemic. Clinicians are resorting to Zoom videoconference, since patients are creating a demand for remote healthcare services. Thus, telemedicine holds promising potentials in revenue generation activities for companies in the dry eye disease treatment market.

More number of patients have been appreciative about telehealth services. This has helped to increase the uptake of anti-inflammatory and artificial tears products. However, clinicians are coming across compliance issues in patients such as erratic consumption of their omega-3 fatty acid supplements. Hence, doctors are holding positive hopes for the pandemic to subside soon so that they can provide written prescriptions and special instructions to patients for effective management of DED. This is likely to drive the dry eye disease treatment market.

Intense Pulsed Light Technology Devices Help Reduce Inflammation in DED Patients

Although anti-inflammatory and artificial tears products hold a major share of the revenue in the dry eye disease treatment market, manufacturers are innovating in state-of-the-art devices to improve patient outcomes. For instance, Device Technologies AU-a medical devices supplier to Australia and New Zealand, is strengthening its distribution channels for medical equipment manufacturer Quantel Medical’s device LacryStim IPL that helps in treating DED. As such, device manufacturers in the dry eye disease treatment market are gaining proficiency in intense pulsed light technology, which is intended to treat dry eye diseases such as meibomian gland dysfunction. Thus, technological innovations contribute a modest share to the market, which is predicted to expand at a CAGR of ~4% during the forecast period.

Device manufacturers are aiming to acquire European regulatory clearance for the intense pulsed light technology that is instrumental in reducing inflammation in DED patients.

Novel Contact Lenses Emerge as Effective Solution for Dry Eye Disease

Innovative contact lens hold promising potentials for dry eye disease treatment. For instance, Swanson School of Engineering graduate student researcher Alexis Nolfi who is suffering from the disease from the past several years, has introduced CyteSolutions Lens that target inflammatory dry eye pathways. Researchers in the dry eye disease treatment market are collaborating with eye doctors to innovate in contact lenses that are capable of replacing artificial tears products. Such breakthrough innovations are bolstering the growth for the dry eye disease treatment market, which is estimated to cross the value of US$ 8.7 Bn by the end of 2030.

Inadequate relief from artificial tears products are posing as a challenge for companies in the market for dry eye disease treatment. Hence, companies in the market for dry eye disease should collaborate with researchers and innovators to design contact lenses that help in the management of inflammatory dry eye pathways.

Multistage Management Algorithm Holds Potential to Prevent Progression of DED

The growing awareness about multistage management algorithm for dry eye disease is acquiring increased credibility, owing to its evidence-based and personalized approach. Healthcare companies in the dry eye disease treatment market are increasing their R&D muscle to develop products that restore the homeostasis of the ocular surface and tear film of the eyes. The Tear Film and Ocular Surface Society (TFOS) is working relentlessly to create awareness about multistage management algorithms for the management of dry eye disease.

Healthcare companies in the dry eye disease treatment market are increasing efforts to educate patients about the negative ramifications of dry eye disease, which is emerging as a key solution to prevent its progression. Manufacturers are increasing their production capabilities to develop fatty acid oral supplements that help to improve overall patient comfort.

Analysts’ Viewpoint

Binge watching streaming TV and spending extensive hours with devices have bolstered the uptake of DED products amidst the COVID-19 outbreak. Manufacturers are increasing their focus in devices with the intense pulsed light technology that is expecting high demand in Europe, whilst the revenue of the dry eye disease treatment market in the region is projected for aggressive growth.

The revenue of anti-inflammatory products is anticipated to take a leap from 42% in 2019 and reach 50% by 2030 during the forecast period. However, clinical evidence of the LASIK (laser in-situ keratomileusis) surgery being ineffective in patients is likely to impede market growth. Hence, companies should innovate in contact lenses that help in treating inflammatory dry eye diseases.

Dry Eye Disease Treatment Market: Overview

  • According to Transparency Market Research’s latest report on the global dry eye disease treatment market for the historical period 2018–2019 and forecast period 2020–2030, rise in reported cases of dry eye disease, increase in the number of surgical procedures such as LASIK surgery, adverse effects of rising pollution levels, advances in treatment of dry eye, and introduction of new therapies are projected to drive the global dry eye disease treatment market
  • According to the report, the global dry eye disease treatment market was valued at US$ 5.4 Bn in 2019 and is anticipated to expand at a CAGR of ~4% from 2020 to 2030

Increase in Reported Cases of Dry Eye Disease: Key Drivers

  • In the U.S., dry eye disease is considered a critical and significant public health issue. An article published in the American Journal of Ophthalmology stated that the estimated prevalence of dry eye disease was 5.28% in the U.S. between 2003 and 2015.
  • According to an article published in the Journal of Ophthalmology, prevalence and incidence of dry eye disease vary from 5% to 50% and the prevalence is rising due to higher incidence of some risk factors and gradual aging of the population. Hence, rise in prevalence of dry eye disease is expected to drive the market.
  • Production of tears decreases with age. This, in turn, is anticipated to increase the prevalence of dry eye in elderly people. Moreover, use of several classes of medicines have been hypothesized as a major cause of dry eye, especially in the elderly. For instance, according to an article published in the American Journal of Ophthalmology, in the U.S., prevalence of dry eye disease increased with age from 0.20% for ages 2 to 17 years to 11.66% for individuals aged 50+. According to the World Health Organization (WHO) projections (2018), the global geriatric population is expected to reach about 1.5 billion by 2050.
  • Dry eye is one of the common problems, which occurs when eyes do not produce enough tears. Several factors can cause dry eyes including natural aging and side effects of drugs such as histamines. Additionally, diabetes increases the risk of dry eye disease. Moreover, people who wear contact lenses complain of dry eye disease.

Advances in Treatment of Dry Eye and Product Approvals & Launches to Augment Global Market

  • Wize Pharma, Inc. is a clinical stage biopharmaceutical company focused on the treatment of ophthalmic disorders, including dry eye syndrome and other inflammatory conditions. The company’s LO2A Eye Drops is an artificial tear currently registered and marketed in Germany and Switzerland for the treatment of dry eye syndrome. It has also been registered in several other countries in Europe.
  • A newly developed treatment strategy for dry eye disease is tear film-oriented therapy. It is a treatment concept for dry eye recommended by the Japanese Dry Eye Society and Asia Dry Eye Society.
  • Novaliq is a pharmaceutical company focusing on the development and commercialization of ocular therapeutics based on EyeSol water-free technology. The company has two investigational drug designs to target predominantly evaporative or aqueous dry eye disease. Its NOV03 and CyclASol are currently in phase 3 development. Bausch Health Companies, Inc. acquired exclusive license from Novaliq GmbH for the development and commercialization of the investigational treatment NOV03 to treat dry eye disease in the U.S. and Canada.

Introduction of New Generics and Over-reliance on OTC Products to Hamper Global Market

  • Over-the-counter (OTC) artificial tears were used as the first line of treatment of dry eye syndrome in the last few decades. Several products are commercially available in the market for artificial tears. Hence, increase in the use of over-the-counter medications for the treatment of dry eye is likely to hamper the growth of the market.
  • Moreover, key players operating in the market are engaged in developing generic products. Therefore, the introduction of generic products increases the pricing pressure on branded prescription products, thereby restraining the market. For instance, in May 2018, Teva Pharmaceutical Industries Ltd. launched the generic version of Restasis in Canada for the treatment of dry eye disease.

North America to Account for Major Share of Dry Eye Disease Treatment Market

  • North America is projected to account for leading share of the global dry eye disease treatment market due to rise in product approvals, well-established healthcare infrastructure, increase in technological advancements, rise in number of well-equipped laboratories, surge in research & developmental activities in dry eye disease, growing healthcare industry, and presence of key players
  • The dry eye disease treatment market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period due to increase in geriatric population, rise in research & developmental activities, surge in initiatives by governments in the healthcare sector, and rise in interest of key players in expanding presence in the region

Dry Eye Disease Treatment Market: Competition Landscape

  • This report profiles major players in the global dry eye disease treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Key players operating in the global dry eye disease treatment market include 
    • Novartis AG
    • Allergan
    • Bausch Health Companies, Inc.
    • Santen Pharmaceutical Co., Ltd.
    • OASIS Medical
    • Sun Pharmaceutical Industries Ltd.
    • Johnson & Johnson
    • Otsuka Pharmaceutical Co., Ltd.
    • Sentiss Pharma Pvt. Ltd.
    • RegeneRx (ReGenTree, LLC)

Dry Eye Disease Treatment Market: Key Developments

  • Key players in the global dry eye disease treatment market have adopted strategies such as regulatory approvals, advanced product development, launch of new products, increase in investments and funds, and acquisition & collaborative agreements with other companies. These strategies by key players are likely to fuel the growth of the global dry eye disease treatment market. A few strategies adopted by players operating in the global dry eye disease treatment market are:
    • In July 2019, Novartis AG completed the acquisition of Xiidra. This acquisition enabled the company to strengthen its product portfolio.
    • In July 2019, Allergan announced the launch of Refresh Relieva products: Refresh Relieva, Refresh Relieva PF (preservative-free) multidose, and Refresh Relieva for Contacts. This enabled the company to expand the robust artificial tear portfolio with innovations in eye care.
    • In June 2019, Sun Pharma entered into an exclusive licensing agreement for the development and commercialization of Cyclosporine A with China Medical System Holdings Ltd. (CMS)
  • The report on the global dry eye disease treatment market discusses individual strategies followed by company profiles of manufacturers of dry eye disease treatment products. The competition landscape section has been included in the dry eye disease treatment market report to provide readers with a dashboard view and a company market share analysis of key players operating in the global dry eye disease treatment market.

Dry Eye Disease Treatment Market – Segmentation

Product

Artificial Tears

Anti-inflammatory

  • Cyclosporine
  • Corticosteroid
  • Others

Punctal Plugs

Secretagogue

Others

Disease

Evaporative Dry Eye Syndrome

Aqueous Dry Eye Syndrome

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Dry Eye Disease Treatment Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of dry eye disease treatment market?

Dry eye disease treatment market to reach valuation of US$ 8.7 Bn by 2030

What is the anticipated CAGR of the dry eye disease treatment market in the forecast period?

Dry eye disease treatment market is projected to expand at a CAGR of ~4% from 2020 to 2030

What are the key driving factors for the growth of the dry eye disease treatment market?

Dry eye disease treatment market is driven by rise in incidence of dry eye disease and increase in R&D activities

Which is the rising prominent segment in the dry eye disease treatment market?

The anti-inflammatory segment is anticipated to account for major share of the global dry eye disease treatment market

Who are the key players in the global dry eye disease treatment market?

Key players in the global dry eye disease treatment market include Novartis AG, Allergan, Bausch Health Companies, Inc., Santen Pharmaceutical Co., Ltd., OASIS Medical

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Dry Eye Disease Treatment Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Dry Eye Disease Treatment Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Global Dry Eye Disease Treatment Market: Key Mergers & Acquisitions

    5.2. Pipeline Analysis

    5.3. Disease Prevalence & Incidence Rate Globally with Key Countries

    5.4. Technological Advancement

    5.5. COVID-19 Pandemics Impact on Industry (Short / Mid / Long Term Impact)

6. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Product 

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Dry Eye Disease Treatment Market Value Forecast, by Product, 2018–2030

        6.2.1. Artificial Tears

        6.2.2. Anti-inflammatory

            6.2.2.1. Cyclosporine

            6.2.2.2. Corticosteroid

            6.2.2.3. Others

        6.2.3. Punctal Plugs

        6.2.4. Secretagogue

        6.2.5. Others 

    6.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Product

7. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Disease 

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Dry Eye Disease Treatment Market Value Forecast, by Disease, 2018–2030

        7.2.1. Evaporative Dry Eye Syndrome

        7.2.2. Aqueous Dry Eye Syndrome 

    7.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease

8. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Distribution Channel 

    8.1. Introduction & Definition

        8.1.1. Key Findings / Developments

    8.2. Global Dry Eye Disease Treatment Market Value Forecast, by Distribution Channel, 2018–2030

        8.2.1. Hospital Pharmacies

        8.2.2. Retail Pharmacies

        8.2.3. Online Pharmacies

    8.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel

9. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Dry Eye Disease Treatment Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Region

10. North America Dry Eye Disease Treatment Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings 

    10.2. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

        10.2.1. Artificial Tears

        10.2.2. Anti-inflammatory

            10.2.2.1. Cyclosporine

            10.2.2.2. Corticosteroid

            10.2.2.3. Others

        10.2.3. Punctal Plugs

        10.2.4. Secretagogue

        10.2.5. Others

    10.3. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

        10.3.1. Evaporative Dry Eye Syndrome

        10.3.2. Aqueous Dry Eye Syndrome 

    10.4. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        10.4.1. Hospital Pharmacies

        10.4.2. Retail Pharmacies

        10.4.3. Online Pharmacies

    10.5. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Dry Eye Disease Treatment Market Attractiveness Analysis 

        10.6.1. By Product

        10.6.2. By Disease 

        10.6.3. By Distribution Channel

        10.6.4. By Country

11. Europe Dry Eye Disease Treatment Market Analysis and Forecast 

    11.1. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

        11.1.1. Artificial Tears

        11.1.2. Anti-inflammatory

            11.1.2.1. Cyclosporine

            11.1.2.2. Corticosteroid

            11.1.2.3. Others

        11.1.3. Punctal Plugs

        11.1.4. Secretagogue

        11.1.5. Others 

    11.2. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

        11.2.1. Evaporative Dry Eye Syndrome

        11.2.2. Aqueous Dry Eye Syndrome

    11.3. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        11.3.1. Hospital Pharmacies

        11.3.2. Retail Pharmacies

        11.3.3. Online Pharmacies 

    11.4. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        11.4.1. Germany

        11.4.2. U.K.

        11.4.3. France

        11.4.4. Spain

        11.4.5. Italy

        11.4.6. Rest of Europe 

    11.5. Europe Dry Eye Disease Treatment Market Attractiveness Analysis 

        11.5.1. By Product 

        11.5.2. By Disease

        11.5.3. By Distribution Channel

        11.5.4. By Country/Sub-region

12. Asia Pacific Dry Eye Disease Treatment Market Analysis and Forecast 

    12.1. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

        12.1.1. Artificial Tears

        12.1.2. Anti-inflammatory

            12.1.2.1. Cyclosporine

            12.1.2.2. Corticosteroid

            12.1.2.3. Others

        12.1.3. Punctal Plugs

        12.1.4. Secretagogue

        12.1.5. Others

    12.2. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

        12.2.1. Evaporative Dry Eye Syndrome

        12.2.2. Aqueous Dry Eye Syndrome

    12.3. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        12.3.1. Hospital Pharmacies

        12.3.2. Retail Pharmacies

        12.3.3. Online Pharmacies 

    12.4. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        12.4.1. China

        12.4.2. Japan

        12.4.3. India

        12.4.4. Australia & New Zealand

        12.4.5. Rest of Asia Pacific 

    12.5. Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis 

        12.5.1. By Product 

        12.5.2. By Disease

        12.5.3. By Distribution Channel

        12.5.4. By Country/Sub-region

13. Latin America Dry Eye Disease Treatment Market Analysis and Forecast 

    13.1. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

        13.1.1. Artificial Tears

        13.1.2. Anti-inflammatory

            13.1.2.1. Cyclosporine

            13.1.2.2. Corticosteroid

            13.1.2.3. Others

        13.1.3. Punctal Plugs

        13.1.4. Secretagogue

        13.1.5. Others 

    13.2. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

        13.2.1. Evaporative Dry Eye Syndrome

        13.2.2. Aqueous Dry Eye Syndrome

    13.3. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        13.3.1. Hospital Pharmacies

        13.3.2. Retail Pharmacies

        13.3.3. Online Pharmacies 

    13.4. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        13.4.1. Brazil

        13.4.2. Mexico

        13.4.3. Rest of Latin America Latin America 

    13.5. Latin America Dry Eye Disease Treatment Market Attractiveness Analysis 

        13.5.1. By Product

        13.5.2. By Disease 

        13.5.3. By Distribution Channel

        13.5.4. By Country/Sub-region

14. Middle East & Africa Dry Eye Disease Treatment Market Analysis and Forecast

        14.1.1.  

    14.2. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

        14.2.1. Artificial Tears

        14.2.2. Anti-inflammatory

            14.2.2.1. Cyclosporine

            14.2.2.2. Corticosteroid

            14.2.2.3. Others

        14.2.3. Punctal Plugs

        14.2.4. Secretagogue

        14.2.5. Others 

    14.3. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

        14.3.1. Evaporative Dry Eye Syndrome

        14.3.2. Aqueous Dry Eye Syndrome

    14.4. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        14.4.1. Hospital Pharmacies

        14.4.2. Retail Pharmacies

        14.4.3. Online Pharmacies 

    14.5. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa 

    14.6. Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis 

        14.6.1. By Product 

        14.6.2. By Disease

        14.6.3. By Distribution Channel

        14.6.4. By Country/Sub-region

15. Competitive Landscape

    15.1. Market Player - Competition Matrix (by Tier and Size of companies)

    15.2. Market Share / Position Analysis, by Company, 2018

    15.3. Competitive Business Strategies

    15.4. Company Profiles

        15.4.1. Novartis AG

            15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.1.2. Growth Strategies

            15.4.1.3. SWOT Analysis

        15.4.2. Allergan

            15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.2.2. Growth Strategies

            15.4.2.3. SWOT Analysis

        15.4.3. Santen Pharmaceutical Co., Ltd.

            15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.3.2. Growth Strategies

            15.4.3.3. SWOT Analysis

        15.4.4. OASIS Medical

            15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.4.2. Growth Strategies

            15.4.4.3. SWOT Analysis

        15.4.5. Sun Pharmaceutical Industries Ltd.

            15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.5.2. Growth Strategies

            15.4.5.3. SWOT Analysis

        15.4.6. Johnson & Johnson

            15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.6.2. Growth Strategies

            15.4.6.3. SWOT Analysis

        15.4.7. Otsuka Pharmaceutical Co., Ltd.

            15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.7.2. Growth Strategies

            15.4.7.3. SWOT Analysis

        15.4.8. Sentiss Pharma Pvt. Ltd.

            15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.8.2. Growth Strategies

            15.4.8.3. SWOT Analysis 

        15.4.9. RegeneRx (ReGenTree, LLC)

            15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.9.2. Growth Strategies

            15.4.9.3. SWOT Analysis

        15.4.10. Bausch Health Companies, Inc.

            15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.10.2. Growth Strategies

            15.4.10.3. SWOT Analysis

List of Tables

Table 1: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 2: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 3: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 4: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 5: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 6: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 7: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 8: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 9: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 10: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 11: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 12: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 13: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 14: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 15: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 16: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 17: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 18: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 19: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 20: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 21: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 22: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 23: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 24: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 25: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 26: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 27: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 28: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 29: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 30: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

List of Figures

Figure 01: Global Dry Eye Disease Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2030

Figure 02: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 03: Global Dry Eye Disease Treatment Market Value Share (%), by Product, 2019

Figure 04: Global Dry Eye Disease Treatment Market Value Share (%), by Disease, 2019

Figure 05: Global Dry Eye Disease Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 06: Global Dry Eye Disease Treatment Market Value Share (%), by Region, 2019

Figure 07: Global Dry Eye Disease Treatment Market Value Share Analysis (%), by Product, 2019 and 2030

Figure 08: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030

Figure 09: Global Dry Eye Disease Treatment Market Value Share (%), by Anti-inflammatory, 2019 and 2030

Figure 10: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Artificial Tears, 2018–2030

Figure 11: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anti-inflammatory, 2018–2030

Figure 12: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Secretagogue, 2018–2030

Figure 13: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Punctal Plugs, 2018–2030

Figure 14: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018–2030

Figure 15: Global Dry Eye Disease Treatment Market Value Share (%) Analysis, by Disease, 2019 and 2030

Figure 16: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 17: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Evaporative Dry Eye Syndrome, 2018–2030

Figure 18: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aqueous Dry Eye Syndrome, 2018–2030

Figure 19: Global Dry Eye Disease Treatment Market Value Share (%)Analysis, by Distribution Channel, 2019 and 2030

Figure 20: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 21: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018–2030

Figure 22: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018–2030

Figure 23: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018–2030

Figure 24: Global Dry Eye Disease Treatment Market Value Share Analysis, by Region, 2019 and 2030

Figure 25: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Region, 2020–2030

Figure 26: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 27: North America Dry Eye Disease Treatment Market Value Share Analysis, by Country, 2019 and 2027

Figure 28: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Country, 2020–2030

Figure 29: North America Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030

Figure 30: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030

Figure 31: North America Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030

Figure 32: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 33: North America Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 34: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 35: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 36: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 37: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 38: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030

Figure 39: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030

Figure 40: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030

Figure 41: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 42: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 43: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 44: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 45: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027

Figure 46: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 47: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030

Figure 48: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030

Figure 49: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030

Figure 50: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 51: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 52: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 53: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 54: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027

Figure 55: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 56: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030

Figure 57: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030

Figure 58: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030

Figure 59: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 60: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 61: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 62: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 63: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027

Figure 64: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 65: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030

Figure 66: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030

Figure 67: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030

Figure 68: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 69: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 70: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

679

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved